Targeted Medical Pharma, Inc. reported earnings results for the third quarter of 2014. For the quarter, the company reported total revenue of $1.7 million, a 24% decrease from $2.2 million during the three months ended September 30, 2013. Adjusted LBITDA of $0.3 million, a 73% improvement from $1.1 million during the three months ended September 30, 2013.

Net loss was $1.0 million compared to a net loss of $1.7 million for the three months ended September 30, 2013.